Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Agora Data Expands Auto Dealer Funding Program with More Competitive Rates and Higher Advances
-
22nd Century Group to Announce Third Quarter 2026 Results on November 16, 2026
-
Alamar Biosciences Partners with GSK on Large-Scale Proteomic Study to Advance Precision Medicine
-
Premium Global Income Split Fund Declares Monthly Distribution
-
FLINT Announces Third Quarter 2026 Financial Results
-
Premium Income Corporation Announces Monthly Distribution
-
Aura Biosciences to Participate in Upcoming Investor Conference
-
Globus Medical Acquires Synaptive Medical, Strengthening Its Position in Cranial Neurosurgery
-
First Acceptance Corporation Reports Operating Results for the Three and Nine Months Ended September 30, 2026
-
Mulvihill Split Preferred Share ETF Declares Monthly Distribution
-
Mulvihill Canadian Bank ETF Declares Monthly Distribution
-
Flywire Reports Third Quarter 2026 Financial Results
-
Mulvihill Canadian Bank Enhanced Yield ETF Declares Monthly Distribution
-
Curaleaf Reports Third Quarter 2026 Results: Record Revenue and Robust Profitability
-
AMGEN REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS
-
RAMACO RESOURCES REPORTS THIRD QUARTER 2026 RESULTS
-
Red Rock Resorts Announces Third Quarter 2026 Results
-
Transcat Reports Strong Fiscal Second Quarter 2027 Financial Results with Double-Digit Service Organic Revenue* Growth and Significant Service Gross Margin Expansion
-
Key Tronic Corporation Announces Results for the First Quarter of Fiscal 2027
-
The Manitowoc Company Reports Strong Third-Quarter 2026 Results; Raises Full Year Guidance
-
Mirum Pharmaceuticals Reports Third Quarter 2026 Financial Results and Provides Business Update
-
Mulvihill Enhanced Split Preferred Share ETF Declares Monthly Distribution
-
Mulvihill Premium Yield Fund Declares Monthly Distribution for Its ETF Class
-
AtriCure Reports Third Quarter 2026 Financial Results
-
Nurix Therapeutics Announces Sanofi’s Decision to Discontinue Development of STAT6 Degrader SAR448272
-
SLR Investment Corp. Announces Quarter Ended September 30, 2026 Financial Results
-
Ultragenyx Reports Third Quarter 2026 Financial Results, Announces Substantial Expense Reductions, and Reaffirms Profitability in 2027
-
Skyworks Begins New Chapter Following Qorvo Combination; Reports Fourth Quarter and Fiscal 2026 Results
-
Aquestive Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update
-
Avis Budget Group Reports Third Quarter 2026 Results
-
Mulvihill Split Capital Share ETF Declares Monthly Distribution
-
Greif Reports Fourth Quarter and Fiscal 2026 Results
-
Denali Therapeutics Reports Third Quarter 2026 Financial Results and Business Highlights
-
United Fire Group, Inc. reports third quarter 2026 results
-
Ardelyx Reports Third Quarter 2026 Financial Results and Provides Business Update
-
Atlanticus to Participate in KBW Fintech Ecosystem Conference
-
Monte Rosa Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Duolingo Reports Third Quarter 2026 Results
-
Spyre Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update
-
Mulvihill Corporate Bond Fund Declares Monthly Distribution for Its ETF Class
-
ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
-
Xenon to Present at Upcoming Investor Conferences
-
Crexendo Announces Strong Third Quarter 2026 Results
-
Dr. James Charasika Scholarship for Medical Students Announces 2026 Winner
-
Astec Announces Board Transition; Appoints John Keating to Board of Directors
-
Cytokinetics to Participate in November Investor Conferences
-
Alkermes to Present at Upcoming Investor Conferences
-
Arrowhead Pharmaceuticals to Webcast 2026 Fiscal Year-End Results
-
Altaba Announces Liquidating Distribution of $0.36 Per Share
-
NYSE American to Commence Delisting Proceedings Against Green Circle Decarbonize Technology Limited (GCDT)
